Author

Ryan R. Friess

University of Minnesota

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Anders J. LindstedtiD· 1 shared Anders W. MatsoniD· 1 shared Bruce K. WalcheckiD· 1 shared Emily Nestor TruckenbrodiD· 1 shared Jeffrey S. MilleriD· 1 shared Jianming WuiD· 1 shared Kate J. DixoniD· 1 shared Martin FelicesiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Anders J. LindstedtORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells

Anders W. Matson, Robert Hullsiek, Kate J. Dixon, Sam C. Wang, Anders J. Lindstedt, Ryan R. Friess, Shee Kwan Phung, Tanya S. Freedman, Martin Felices, Emily Nestor Truckenbrod, Jianming Wu, Jeffrey S. Miller, Bruce K. Walcheck

This study shows that an ADAM17-blocking antibody enhances IL-15-mediated NK cell activation and proliferation through CD16A and CD137, with potential therapeutic applications in cancer.

Journal for ImmunoTherapy of Cancer · Jul 1, 2024Peer-reviewedImmunology